The Agency for Healthcare Research and Quality today released a toolkit to help hospitals prevent catheter-associated urinary tract infections, which is based on an AHRQ program administered by the AHA’s Health Research & Educational Trust, among others. More than 1,200 hospitals participated in the Comprehensive Unit-based Safety Program, launched in 2011, which reduced CAUTI rates by about 15%, according to preliminary results. The program also reduced other healthcare-associated infections, such as central line-associated bloodstream infections. The CAUTI toolkit includes checklists and modifiable teaching tools to help clinical teams and resident physicians and nurses in intensive care units adhere to Centers for Disease Control and Prevention guidelines that call for urinary catheters to be removed as soon as possible. “We used this toolkit to take a fresh look at our entire approach to the use of catheters,” said Cheryl Davis, R.N., senior nurse epidemiologist in the Infection Prevention Department of Saint Luke’s Hospital, Kansas City, MO. “Not only have we reduced CAUTI rates, but we’ve also reduced catheter use overall, which makes patients significantly safer and more comfortable.”

Related News Articles

Headline
Hospitals, health systems and other health care organizations can sign up this week to host an intern for this year's Institute for Diversity and Health Equity…
Headline
The Centers for Disease Control and the National Tuberculosis Controllers Association this week released updated recommendations for TB screening and testing…
Headline
The House Ways and Means Committee today held a hearing examining the impact of racial disparities and social determinants of health on maternal mortality.
Headline
The Centers for Medicare…
Headline
The Food and Drug Administration last week alerted health care providers and patients that batteries in certain Medtronic implantable pacemakers and cardiac…
Headline
The Food and Drug Administration Friday issued final guidance clarifying how sponsors may show that a proposed biosimilar product is interchangeable with a…